These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1317533)

  • 1. Recombinant human erythropoietin treatment reverses hepatic iron overload in hemodialysis patients.
    Berland Y; Baz M; Di Stefano D; Merzouk T; Bartoli JM; Dussol B; Kasbarian M
    Nephrol Dial Transplant; 1992; 7(4):366-7. PubMed ID: 1317533
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
    Lazarus JM; Hakim RM; Newell J
    Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: confirmation by follow-up liver biopsy.
    Onoyama K; Nakamura S; Yamamoto M; Kawadoko T; Nanishi F; Komoda T; Murai K; Fujishima M
    Nephron; 1990; 56(3):325-8. PubMed ID: 2077417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy.
    McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP
    J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients.
    Boelaert JR; Cantinieaux BF; Hariga CF; Fondu PG
    Nephrol Dial Transplant; 1990; 5(7):504-17. PubMed ID: 2130296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin.
    Nomura S; Osawa G; Karai M
    Nephron; 1990; 55(2):210-3. PubMed ID: 2362636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
    Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
    Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with recombinant human erythropoietin in hemodialysis patients.
    Schaefer RM; Kuerner B; Zech M; Heidland A
    Pol Arch Med Wewn; 1988 Oct; 80(4):213-20. PubMed ID: 3078210
    [No Abstract]   [Full Text] [Related]  

  • 14. Listeriosis in patients with long-term hemodialysis and transfusional iron overload.
    Mossey RT; Sondheimer J
    Am J Med; 1985 Sep; 79(3):397-400. PubMed ID: 4036991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human recombinant erythropoietin treatment on erythrocyte delta-aminolevulinic acid dehydratase in patients on maintenance hemodialysis.
    Djordjević VB; Pavlović D; Pejović M; Lecić N; Koraćević D; Djordjević V; Stefanović V
    Nephron; 1993; 65(3):497-8. PubMed ID: 8290015
    [No Abstract]   [Full Text] [Related]  

  • 16. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
    Tarng DC; Huang TP; Chen TW
    Am J Nephrol; 1997; 17(2):158-64. PubMed ID: 9096447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucormycosis in a hemodialysis patient with iron overload].
    Arimura Y; Nakabayashi K; Kitamoto K; Nagasawa T; Tanaka U; Nakamura W; Fujita C; Takimoto M
    Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1884-7. PubMed ID: 3074984
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients.
    Agroyannis B; Koutsicos D; Tzanatou-Exarchou H; Varsou-Papadimitriou E; Kapetanaki A; Yatzidis H
    Int J Artif Organs; 1991 Jul; 14(7):403-6. PubMed ID: 1889892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant human erythropoietin (epoetin) and autologous blood transfusion in chronic hemodialysis. Apropos of 2 cases].
    Montagnac R; Ebikili B; Schillinger F
    Nephrologie; 1997; 18(1):23-6. PubMed ID: 9121601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?
    Goodnough LT; Strasburg D; Riddell J; Verbrugge D; Wish J
    Clin Nephrol; 1994 May; 41(5):303-7. PubMed ID: 8050211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.